Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study

BACKGROUND: No phase 3 studies have yet been conducted for patients with non–clear cell (CC) renal cell carcinoma (RCC) exclusively due to the rare occurrence of the disease and the heterogenicity in tumor morphology. Consequently, there is no evidence of the optimal treatment, and new approaches ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Ida Marie Lind, Soerensen, Anne Vest, Møller, Anne Kirstine, Persson, Gitte Fredberg, Palshof, Jesper Andreas, Taarnhøj, Gry Assam, Pappot, Helle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523525/
https://www.ncbi.nlm.nih.gov/pubmed/36107483
http://dx.doi.org/10.2196/36632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523525/
https://www.ncbi.nlm.nih.gov/pubmed/36107483
http://dx.doi.org/10.2196/36632

Ejemplares similares